The Brito Lab (Institute of Neurosciences, University of Barcelona, and IDIBAPS) investigates how the mutant Huntingtin gene drives selective neurodegeneration in Huntington’s disease (HD) and aims to translate this knowledge into new therapeutic strategies.
We are seeking a postdoctoral researcher to join an ongoing project exploring how N⁶-methyladenosine (m⁶A) RNA modifications regulate the generation of toxic HTT1a transcripts. Building on our recent findings, the project will elucidate the molecular links between m⁶A deposition, transcriptional dynamics, DNA repair, and aberrant RNA processing within the HTT gene.
This work integrates advanced RNA mapping (Oxford Nanopore Direct RNA sequencing) and CRISPR-based RNA editing tools to define how m⁶A shapes HTT1a expression and to develop new epitranscriptomic strategies for therapeutic intervention. The postdoc will lead molecular and cellular assays, including RNA–protein interaction studies, RNA modification detection, and functional validation in cellular and mouse models.